Carlos Daniel Coda Zabetta
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Carlos Daniel Coda Zabetta has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Claudio Tiribelli
Metabolic Liver Disease Unit, Fondazione Italiana Fegato, 34149 Trieste, Italy
2 shared publications - Cristina Bellarosa
Innovative Models Unit, Fondazione Italiana Fegato (Italian Liver Foundation), 34149 Trieste, Italy
2 shared publications - Chiara Greco
Institute for Maternal and Child Health - IRCCS Burlo Garofolo, Trieste, Italy
1 shared publication I.F. Iskander
1 shared publication- Mohammed Qaisiya
Fondazione Italiana Fegato ONLUS, Italian Liver Foundation ONLUS, AREA Science Park Basovizza Bldg Q, 34149, Trieste, Italy.
1 shared publication R.P. Wennberg
1 shared publication
Latest Publications
- 1 March 2014
- Published by Elsevier in Cellular Signalling
- Vol. 26 (3) , 512-520
Bilirubin mediated oxidative stress involves antioxidant response activation via Nrf2 pathway
- 1 March 2014
- Published by Elsevier in Cellular Signalling
- Vol. 26 (3) , 512-520
Bilirubin mediated oxidative stress involves antioxidant response activation via Nrf2 pathway
- 22 December 2012
- Published by S. Karger AG in Neonatology
- Vol. 103 (3) , 177-181
Bilistick: A Low-Cost Point-of-Care System to Measure Total Plasma Bilirubin
Background: Severe neonatal hyperbilirubinemia, with consequent encephalopathy, remains a common cause of morbidity and death in many regions of the world. Poor access to clinical laboratory resources and screening programs to measure plasma bilirubin levels is a major contributor to delayed treatment in developing countries, and the cost of existing point-of-care screening instruments precludes their dissemination. Objectives: We are evaluating the accuracy of a low-cost, minimally invasive point-of-care system (Bilistick) requiring a 25-µl blood sample that could be used in low-resource environments to evaluate patients with neonatal jaundice. Methods: We compared plasma bilirubin levels in divided blood samples by clinical laboratories and by Bilistick at two medical centers serving term and near-term newborns from ethnically different populations. Results: 118 neonates with bilirubin levels ranging from 24.8 to 501.0 µmol/l were analyzed. The mean bilirubin concentration (±SD) was 215.6 ± 85.5 µmol/l for Bilistick and 226.1 ± 86.4 µmol/l by laboratory determination. Pearson’s correlation coefficient between all paired results was 0.961, and the Bland-Altman analysis showed a mean difference of 10.3 µmol/l with a 95% interval of agreement of –38.0 to 58.7 µmol/l. Conclusion: Bilistick is a minimally invasive method for measuring total bilirubin concentration over a wide range of values and should provide an affordable and accurate system for pre-discharge and follow-up screening of jaundiced infants, particularly in low-resource environments.
- 22 December 2012
- Published by S. Karger AG in Neonatology
- Vol. 103 (3) , 177-181
Bilistick: A Low-Cost Point-of-Care System to Measure Total Plasma Bilirubin
Background: Severe neonatal hyperbilirubinemia, with consequent encephalopathy, remains a common cause of morbidity and death in many regions of the world. Poor access to clinical laboratory resources and screening programs to measure plasma bilirubin levels is a major contributor to delayed treatment in developing countries, and the cost of existing point-of-care screening instruments precludes their dissemination. Objectives: We are evaluating the accuracy of a low-cost, minimally invasive point-of-care system (Bilistick) requiring a 25-µl blood sample that could be used in low-resource environments to evaluate patients with neonatal jaundice. Methods: We compared plasma bilirubin levels in divided blood samples by clinical laboratories and by Bilistick at two medical centers serving term and near-term newborns from ethnically different populations. Results: 118 neonates with bilirubin levels ranging from 24.8 to 501.0 µmol/l were analyzed. The mean bilirubin concentration (±SD) was 215.6 ± 85.5 µmol/l for Bilistick and 226.1 ± 86.4 µmol/l by laboratory determination. Pearson’s correlation coefficient between all paired results was 0.961, and the Bland-Altman analysis showed a mean difference of 10.3 µmol/l with a 95% interval of agreement of –38.0 to 58.7 µmol/l. Conclusion: Bilistick is a minimally invasive method for measuring total bilirubin concentration over a wide range of values and should provide an affordable and accurate system for pre-discharge and follow-up screening of jaundiced infants, particularly in low-resource environments.